To investigate autonomic nervous system (ANS) regulation of the pulmonary vascular response to increasing cardiac index (CI:ml/min/kg) following systemic hypotension (H), the pulmonary vascular ...
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide and is characterized by chronic inflammation in both the pulmonary compartment and the rest of the ...
The randomized, double-blind, placebo-controlled, phase 3 SENSCIS trial enrolled 576 patients who were randomly assigned to twice-daily oral nintedanib 150 mg or placebo. The primary endpoint — annual ...
Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation ...
The FDA has approved Actemra® (tocilizumab; Genentech) subcutaneous injection for slowing the rate of decline in pulmonary function in SSc-ILD. The Food and Drug Administration (FDA) has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback